138 related articles for article (PubMed ID: 14703105)
1. Morphological and functional changes of human vocal fold fibroblasts with hepatocyte growth factor.
Hirano S; Bless DM; Massey RJ; Hartig GK; Ford CN
Ann Otol Rhinol Laryngol; 2003 Dec; 112(12):1026-33. PubMed ID: 14703105
[TBL] [Abstract][Full Text] [Related]
2. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts.
Hirano S; Bless D; Heisey D; Ford C
Laryngoscope; 2003 Jan; 113(1):144-8. PubMed ID: 12514399
[TBL] [Abstract][Full Text] [Related]
3. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model.
Hirano S; Bless DM; Rousseau B; Welham N; Montequin D; Chan RW; Ford CN
Laryngoscope; 2004 Mar; 114(3):548-56. PubMed ID: 15091233
[TBL] [Abstract][Full Text] [Related]
4. Primed fibroblasts and exogenous decorin: potential treatments for subacute vocal fold scar.
Krishna P; Rosen CA; Branski RC; Wells A; Hebda PA
Otolaryngol Head Neck Surg; 2006 Dec; 135(6):937-45. PubMed ID: 17141088
[TBL] [Abstract][Full Text] [Related]
5. Vocal fold fibroblast response to growth factor treatment is age dependent: results from an in vitro study.
Graupp M; Kiesler K; Friedrich G; Ainödhofer H; Gruber HJ; Kieslinger P; Saxena A; Hirano S; Gugatschka M
J Voice; 2014 Jul; 28(4):420-3. PubMed ID: 24495429
[TBL] [Abstract][Full Text] [Related]
6. Fibroblasts in human vocal fold mucosa.
Hirano M; Sato K; Nakashima T
Acta Otolaryngol; 1999 Mar; 119(2):271-6. PubMed ID: 10320090
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of growth factors for aging voice.
Hirano S; Bless DM; del Río AM; Connor NP; Ford CN
Laryngoscope; 2004 Dec; 114(12):2161-7. PubMed ID: 15564837
[TBL] [Abstract][Full Text] [Related]
8. Fibroblasts in the human vocal fold mucosa: an ultrastructural study of different age groups.
Awd Allah RS; Dkhil MA; Farhoud E
Singapore Med J; 2009 Feb; 50(2):201-7. PubMed ID: 19296037
[TBL] [Abstract][Full Text] [Related]
9. The effects of decorin and HGF-primed vocal fold fibroblasts in vitro and ex vivo in a porcine model of vocal fold scarring.
Krishna P; Regner M; Palko J; Liu F; Abramowitch S; Jiang J; Wells A
Laryngoscope; 2010 Nov; 120(11):2247-57. PubMed ID: 20830759
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor and its receptor c-met in rat and rabbit vocal folds.
Hirano S; Thibeault S; Bless DM; Ford CN; Kanemaru S
Ann Otol Rhinol Laryngol; 2002 Aug; 111(8):661-6. PubMed ID: 12184584
[TBL] [Abstract][Full Text] [Related]
11. Effect of exogenous hepatocyte growth factor on vocal fold fibroblasts.
Kishimoto Y; Hirano S; Suehiro A; Tateya I; Kanemaru S; Nakamura T; Ito J
Ann Otol Rhinol Laryngol; 2009 Aug; 118(8):606-11. PubMed ID: 19746761
[TBL] [Abstract][Full Text] [Related]
12. Modulation of vocal fold scar fibroblasts by adipose-derived stem/stromal cells.
Kumai Y; Kobler JB; Park H; Galindo M; Herrera VL; Zeitels SM
Laryngoscope; 2010 Feb; 120(2):330-7. PubMed ID: 20013848
[TBL] [Abstract][Full Text] [Related]
13. Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts.
Hirano S; Bless DM; Heisey D; Ford CN
Ann Otol Rhinol Laryngol; 2003 Jul; 112(7):617-24. PubMed ID: 12903682
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth factors on extracellular matrix production by vocal fold fibroblasts in 3-dimensional culture.
Luo Y; Kobler JB; Zeitels SM; Langer R
Tissue Eng; 2006 Dec; 12(12):3365-74. PubMed ID: 17518673
[TBL] [Abstract][Full Text] [Related]
15. Regulation of wound healing by granulocyte-macrophage colony-stimulating factor after vocal fold injury.
Lim JY; Choi BH; Lee S; Jang YH; Choi JS; Kim YM
PLoS One; 2013; 8(1):e54256. PubMed ID: 23372696
[TBL] [Abstract][Full Text] [Related]
16. Growth factor therapy for vocal fold scarring in a canine model.
Hirano S; Bless DM; Nagai H; Rousseau B; Welham NV; Montequin DW; Ford CN
Ann Otol Rhinol Laryngol; 2004 Oct; 113(10):777-85. PubMed ID: 15535139
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery system of hepatocyte growth factor for the treatment of vocal fold scarring in a canine model.
Ohno T; Hirano S; Kanemaru S; Yamashita M; Umeda H; Suehiro A; Tamura Y; Nakamura T; Ito J; Tabata Y
Ann Otol Rhinol Laryngol; 2007 Oct; 116(10):762-9. PubMed ID: 17987782
[TBL] [Abstract][Full Text] [Related]
18. Expression and distribution of CD44 and hyaluronic acid in human vocal fold mucosa.
Sato K; Sakamoto K; Nakashima T
Ann Otol Rhinol Laryngol; 2006 Oct; 115(10):741-8. PubMed ID: 17076095
[TBL] [Abstract][Full Text] [Related]
19. Effects of basic fibroblast growth factor on rat vocal fold fibroblasts.
Suehiro A; Hirano S; Kishimoto Y; Tateya I; Rousseau B; Ito J
Ann Otol Rhinol Laryngol; 2010 Oct; 119(10):690-6. PubMed ID: 21049855
[TBL] [Abstract][Full Text] [Related]
20. Towards an in vitro fibrogenesis model of human vocal fold scarring.
Graupp M; Rinner B; Frisch MT; Weiss G; Fuchs J; Sundl M; El-Heliebi A; Moser G; Kamolz LP; Karbiener M; Gugatschka M
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1211-1218. PubMed ID: 29520499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
